News

Media contact:
Molly Bowen  

Combination HIV prevention reduces infections

Post Date: 
2017-12-01
Source: 
MD Magazine
. . . Researchers found that throughout the 7-year period in which rates of treatment and voluntary medical male circumcision increased significantly, HIV incidence dropped by 42% among nearly 18,000 people in Uganda . . .

4 ways that telemedicine can address the opioid crisis

Post Date: 
2017-12-01
Source: 
The Hill
CCGHE Director Dr. Bob Bollinger describes the utility of telemedicine in this opinion article in The Hill.

Male circumcision and antiviral drugs appear to sharply reduce HIV infection rate

Post Date: 
2017-11-29
Source: 
Medical Xpress
. . . The current study, based on RCCS data on 34,000 adults enrolled and followed between 1989 and 2016, confirmed the widespread adoption of many of PEPFAR's HIV prevention measures. The use of antiretroviral therapy among infected people rose steadily from 12 percent in the 2006 survey to 69...

Mexico conference: Experts from BJ Medical College make presentations on TB, treatment

Post Date: 
2017-11-09
Source: 
The Indian Express
Four fellows from the BJGMC-JHU Fogarty HIV-TB Training Program make national headlines in India.

Toward a TB-Free India

Post Date: 
2017-11-09
Source: 
Interagency TB Newsletter
TB research underway by the Indo-JHU clinical research partnership is highlighted in the US Interagency TB Newsletter.

Technology could help opioid addicts in rural America, but a federal rule needs changing

Post Date: 
2017-11-08
Source: 
McClatchy News
CCGHE's Dr. Bob Bollinger discusses the utility of emocha in treating patients in remote areas.

Tech designed for Africa helps US fight disease, save money

Post Date: 
2017-10-12
Source: 
Global Health Matters
Dr. Bob Bollinger talks with the NIH Fogarty Center about development of the emocha mobile health platform.

Bollinger tapped for Fogarty International Center Advisory Board

Post Date: 
2017-10-12
Source: 
Global Health Matters
CCGHE Director joins the Fogarty International Advisory Board, which provides strategic guidance on policies and programs

Efficacy maintained in HIV regimen switch

Post Date: 
2017-10-10
Source: 
MedPage Today
. . . "We still do have a lot of people on protease inhibitors in this country," Chida told MedPage Today. "Data to prove the safety and sustain viral load effect is important" to support decisions about switching. . .

Investigational flu drug a near match for oseltamivir

Post Date: 
2017-10-09
Source: 
MedPage Today
MedPage Today caught up with Dr. Natasha Chida at IDWeek 2017

Reduced Level of Disease Possible in India by the Centennial

Post Date: 
2017-08-22
Source: 
India Abroad
India ranks highest in global disease burden. Dr. Amita Gupta weighs in on how to reverse that.

How can we encourage female leaders in global health?

Post Date: 
2017-08-09
Source: 
Global Health Matters
Fogarty Director Dr. Roger Glass asks why so few women are leading global health centers at med schools or filling other leadership roles.

First lesson of herpes transmission: There is pretty much no way to know who gave you herpes

Post Date: 
2017-08-03
Source: 
SELF Magazine
Kathleen Page talks herpes transmission in a SELF Magazine feature.

Sick and afraid, some immigrants forgo medical care

Post Date: 
2017-06-26
Source: 
The New York Times
Dr. Kathleen Page in the New York Times: US government deportation crackdown is affecting healthcare access among undocumented immigrants.

Emocha Mobile Health expands to opioid addiction treatment

Post Date: 
2017-06-23
Source: 
Baltimore Sun
Baltimore Sun: emocha received award to expand miDOT capabilities to help care providers treat opioid addiction.

emocha is looking to help treat opioid addiction

Post Date: 
2017-06-16
Source: 
Technical.ly Baltimore
emocha received a $1.7 million grant from the National Institute on Drug Abuse to complete the research studies ahead of its commercial release. The technology will be used in clinic-based treatment, with observation of take-home being a next step. The grant will help the startup validate the...

Emocha launches pilot to help recovering opioid addicts

Post Date: 
2017-06-15
Source: 
Baltimore Business Journal
Emocha will be piloting its platform in partnership with two opioid recovery clinics based at the University of Washington in Seattle and Boston University.

Company tests mobile health for tuberculosis treatment

Post Date: 
2017-05-23
Source: 
NIH: News and Events
Preliminary data show 93% treatment adherence using video observation, with savings of more than $1,000 per TB patient over 6 months

Fogarty International Center, a linchpin of global health research

Post Date: 
2017-05-17
Source: 
JAMA
Bob Bollinger weighs in on NIH’s Fogarty Program & the strategic benefits the program offers for US disease surveillance.

Study highlights burden of community-onset antimicrobial resistance in India

Post Date: 
2017-03-21
Source: 
Healio
Healio features an antimicrobial resistance study by Dr. Vidya Mave, et al.

Pages